April 14, 2026 KCNT1-Targeting Antisense Oligonucleotide Reduces Seizures but May Cause Hydrocephalus
April 6, 2026 Isatuximab Improves MRD Negativity in Newly Diagnosed Multiple Myeloma: EMN24 IsKia Trial Results